| Patient | Frances Burney |
|---|---|
| Date of birth | 1967-06-13 |
| Identifiers | MRN HR-EN013-SYN; SSN (made up) 000-13-9108 |
| Document date | 2026-10-29 |
| Author | Harriet Pell, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Adult preventive visit; no new complaints. [S]
Mrs. Burney returns for her yearly preventive visit, ten days after starting anastrozole and four weeks after her right mastectomy. The seroma did not recur after one aspiration, and her wound has healed. Her shoulder movement is nearly full with daily exercises. She has had no hot flashes or joint aches yet on anastrozole and takes vitamin D daily. She walks 30 minutes a day and has begun writing again in the mornings. She completed the health risk assessment before the visit. [S]
| Element | Detail |
|---|---|
| Visit | Adult preventive visit, age 59 |
| Active conditions | Right breast cancer after mastectomy, on anastrozole; low bone mass |
| Medicines | Anastrozole 1 mg daily; vitamin D3 1000 units daily |
| Recent events | Seroma aspirated once, three weeks ago; resolved |
| Functional status | Independent; walking 30 minutes a day |
Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good, and recovering well from surgery |
| Psychosocial | Close to her husband and son; many friends visit; no financial strain; feels safe at home |
| Behavioral | Never smoker; a glass of wine with dinner two or three times a week; walks 30 minutes a day; diet with dairy most days |
| Activities of daily living | Independent in all |
| Instrumental activities of daily living | Manages her own medicines, money, correspondence, and household |
| Home safety | Smoke detectors working; wears a seat belt; no falls |
| Hearing and vision | Reading glasses; eye examination last year; no hearing concern |
| Sleep | About seven hours a night |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; no fever or night sweats |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No hearing change |
| Cardiovascular | Negative | No chest pain, palpitations, or leg swelling |
| Respiratory | Negative | No cough or breathlessness |
| Breast | Negative | No lump or change in the left breast; right chest wall healing |
| Gastrointestinal | Negative | Regular bowels; no blood |
| Genitourinary | Negative | No vaginal bleeding, dryness, or urinary symptoms |
| Musculoskeletal | Negative | No joint aches or bone pain; right shoulder nearly full movement |
| Integumentary | Negative | Wound healed; no new skin lesions |
| Neurological | Negative | No numbness of the arm beyond a small patch under the axilla |
| Psychiatric | Negative | Mood good; PHQ-2 score 0 |
12 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth every 6 hours for pain after surgery, no more than 3000 mg a day | Two tablets every 6 hours | Oral route | 2026-09-30 to 2026-10-14 | completed | S |
| Ibuprofen 400 mg oral tablet, one tablet by mouth every 8 hours with food for five days after surgery | One tablet every 8 hours with food | Oral route | 2026-09-30 to 2026-10-05 | completed | S |
| Anastrozole 1 mg oral tablet, one tablet by mouth once daily, planned for five years | One tablet once daily | Oral route | 2026-10-19 | active | S |
| Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once daily | One tablet once daily | Oral route | 2026-10-19 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-10-29 | Body height | 160 | cm | S |
| 2026-10-29 | Body weight | 61.2 | kg | S |
| 2026-10-29 | Body mass index (BMI) [Ratio] | 23.9 | kg/m2 | S |
| 2026-10-29 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-10-29 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-10-29 | Heart rate | 72 | /min | S |
| 2026-10-29 | Respiratory rate | 14 | /min | S |
| 2026-10-29 | Body temperature | 36.6 | Cel | S |
| 2026-10-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-10-29 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-10-29 | Total score [AUDIT-C] | 2 | {score} | S |
Vital signs recorded on 2026-10-29; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well-appearing; BMI 23.9 |
| Eyes | Pupils equal and reactive |
| Neck | No thyroid enlargement or nodes |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Respiratory | Clear |
| Breasts and chest wall | Right mastectomy scar healed; flap flat with no fluid; left breast without masses |
| Lymph nodes | No axillary or supraclavicular nodes |
| Extremities | Arm circumference 26.0 cm on each side 10 cm above the elbow; right shoulder flexion 165 degrees |
| Abdomen | Soft; no masses |
| Skin | No suspicious lesions |
| Psychiatric | Bright, observant, and engaged |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Invasive ductal carcinoma of the right breast, upper outer quadrant at 10 o'clock, presenting as a firm lump after about a year of breast ache; core biopsy: grade 2, estrogen and progesterone receptor positive, HER2 negative; clinical stage T2 N0 (cT2 cN0 M0); synthetic modern diagnosis linked to the documented 1811 breast disease and mastectomy, whose cancer diagnosis is debated | active | confirmed | C50.411 | S — Synthetic diagnosis confirmed by biopsy and surgical pathology in the modern episode; whether her historical disease was cancer remains a retrospective interpretation (R). |
| Estrogen receptor positive status of the breast cancer (ER 95 percent, PR 70 percent) | active | confirmed | Z17.0 | S — Synthetic receptor result; no tissue from her lifetime was examined. |
| Absence of the right breast after total mastectomy without reconstruction, her choice | active | confirmed | Z90.11 | S — Synthetic coding of the modern mastectomy, which echoes the documented operation. |
| Long-term use of anastrozole as adjuvant endocrine therapy | active | confirmed | Z79.811 | S — Synthetic treatment status. |
| Low bone mass (osteopenia) on baseline DXA before anastrozole: lumbar spine T-score -1.4, femoral neck -1.7; 10-year major osteoporotic fracture risk about 8 percent (FRAX); vitamin D insufficiency | active | confirmed | M85.80 | S — Synthetic finding on the baseline DXA the protocol requires for an aromatase inhibitor. |
| Seroma under the right mastectomy flap after drain removal, without infection; aspirated once by the breast surgery team; resolved | resolved | confirmed | L76.34 | S — Synthetic common complication of the synthetic mastectomy; it does not echo a documented illness. |
| Firm lump in the upper outer quadrant of the right breast after about a year of heavy breast ache; clinically suspicious, imaging and biopsy booked | resolved | confirmed | N63.11 | S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the year of breast ache echoes her documented account (D). |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, 2026-2027 | Completed today | Inactivated vaccine given today |
| Pneumococcal vaccine | Completed today | PCV20 given today; recommended from age 50; no further doses needed |
| Recombinant zoster vaccine | Completed today | Dose 1 today; dose 2 in two to six months |
| COVID-19 vaccine, 2026-2027 | Due | Recommended; she will get it at her pharmacy in two weeks |
| Hepatitis B vaccine | Due | Recommended for adults 19 to 59; series to start at the next visit if the screening test shows no immunity |
| Tetanus booster | Up to date | Tdap six and a half years ago |
| Breast cancer screening | Not indicated | Replaced by surveillance: yearly diagnostic mammogram of the left breast from next August |
| Cervical cancer screening | Up to date | Cytology with HPV co-testing three years ago, normal; next in two years |
| Colorectal cancer screening | Up to date | Colonoscopy eight years ago, normal; next at ten years |
| Osteoporosis screening | Up to date | DXA ten days ago: low bone mass; repeat in two years on anastrozole |
| Hepatitis B, hepatitis C, and HIV screening | Ordered | One-time screening; no prior result on record; drawn today, results pending |
| Cholesterol screening and statin decision | Completed today | Lipid panel ten days ago reviewed; 10-year risk below 5 percent; no statin |
| Diabetes screening | Not indicated | BMI 23.9 without other risk factors |
| Lung cancer screening | Not indicated | Never smoker |
| Blood pressure screening | Completed today | 120/76 mmHg |
| Depression screening | Completed today | PHQ-2 score 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C 2, negative |
| Physical activity and diet counseling | Completed today | 150 minutes of walking a week, strength exercise twice a week once the surgeon allows, and calcium from food |
Immunizations given today: Influenza vaccine, 2026-2027 season; Pneumococcal conjugate vaccine PCV20; Recombinant zoster vaccine, dose 1 of 2 [S]
Guideline basis: Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)
Follow-up: Hepatitis B, hepatitis C, and HIV results by portal message. Second zoster dose in two to six months. Survivorship visit in three months. [S]
Voluntary advance care planning discussion of about 20 minutes, with her consent, prompted by her cancer diagnosis. She has named a health care agent and completed a written health care directive today, now scanned into the chart. She wants to be told plainly and in advance what any treatment would involve. If the cancer returned she would want treatment that offered a real chance of control while she could still live independently and write; she would not want resuscitation or prolonged life support if recovery to independent life were not expected. [S]